A Potential Neuroprotective Role of Apolipoprotein E-containing Lipoproteins through Low Density Lipoprotein Receptor-related Protein 1 in Normal Tension Glaucoma

Background: No effective treatment exists for normal tension glaucoma (NTG), which induces a significant loss of retinal ganglion cells (RGCs). Results: Apolipoprotein E-containing lipoproteins (E-LPs) blocked Ca2+-dependent apoptosis induced by glutamate in RGCs. Conclusion: Administration of E-LPs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2012-07, Vol.287 (30), p.25395-25406
Hauptverfasser: Hayashi, Hideki, Eguchi, Yuko, Fukuchi-Nakaishi, Yuko, Takeya, Motohiro, Nakagata, Naomi, Tanaka, Kohichi, Vance, Jean E., Tanihara, Hidenobu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: No effective treatment exists for normal tension glaucoma (NTG), which induces a significant loss of retinal ganglion cells (RGCs). Results: Apolipoprotein E-containing lipoproteins (E-LPs) blocked Ca2+-dependent apoptosis induced by glutamate in RGCs. Conclusion: Administration of E-LPs protects RGCs from glutamate-induced degeneration in vitro and in vivo. Significance: Protection from neuron death by E-LPs provides a novel strategy of treatment for NTG. Glaucoma is an optic neuropathy and the second major cause of blindness worldwide next to cataracts. The protection from retinal ganglion cell (RGC) loss, one of the main characteristics of glaucoma, would be a straightforward treatment for this disorder. However, the clinical application of neuroprotection has not, so far, been successful. Here, we report that apolipoprotein E-containing lipoproteins (E-LPs) protect primary cultured RGCs from Ca2+-dependent, and mitochondrion-mediated, apoptosis induced by glutamate. Binding of E-LPs to the low density lipoprotein receptor-related protein 1 recruited the N-methyl-d-aspartate receptor, blocked intracellular Ca2+ elevation, and inactivated glycogen synthase kinase 3β, thereby inhibiting apoptosis. When compared with contralateral eyes treated with phosphate-buffered saline, intravitreal administration of E-LPs protected against RGC loss in glutamate aspartate transporter-deficient mice, a model of normal tension glaucoma that causes glaucomatous optic neuropathy without elevation of intraocular pressure. Although the presence of α2-macroglobulin, another ligand of the low density lipoprotein receptor-related protein 1, interfered with the neuroprotective effect of E-LPs against glutamate-induced neurotoxicity, the addition of E-LPs overcame the inhibitory effect of α2-macroglobulin. These findings may provide a potential therapeutic strategy for normal tension glaucoma by an LRP1-mediated pathway.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M112.370130